Literature DB >> 30295916

Astrocyte support is important for the compensatory potential of the nigrostriatal system neurons during early neurodegeneration.

Katarzyna Kuter1, Łukasz Olech1, Urszula Głowacka1, Martyna Paleczna1.   

Abstract

Glial pathology precedes symptoms of Parkinson's disease and multiple other neurodegenerative diseases. Prolonged impairment of astrocytic functions could increase the vulnerability of dopaminergic neurons in the substantia nigra (SN), accelerate their degeneration and affect ability to compensate for partial degeneration at the presymptomatic stages of the disease. The aim of this study was to investigate the astrocyte depletion in the SN, its impact on the dopaminergic system functioning and multiple markers of energy metabolism during the early stages of neurodegeneration and compensation. We induced death of 30% of astrocytes by chronic infusion of fluorocitrate (FC) into the SN, simultaneously activating microglia response but sparing the dopaminergic neurons. The FC effect was reversible after toxin withdrawal. Dopaminergic neurons were killed by 6-hydroxydopamine causing transient locomotor disability, reversed with time showing compensatory potential. Death of astrocytes diminished the capability of the dopaminergic system to compensate for the degeneration of neurons and caused a local energy deprivation by decreasing lactate and glycogen amount. Studied markers suggest a shift in the usage of energy substrates, via increased glycogenolysis and glycolysis markers, ketone bodies availability and fatty acid transport in remaining cells. Peroxisome proliferator-activated receptor-gamma coactivator 1α (PGC-1alpha) and AMP-activated protein kinase (AMPK), the energy sensors, showed different regulation between the cell-types. Increased neuronal expression of carnitine palmitoyltransferase 1c could play a role in the adaptation to metabolic stress in response to glia dysfunction. Astrocyte energetic support is one of the essential factors for neuronal compensatory mechanisms of dopaminergic system and might have a leading role in the presymptomatic Parkinson's disease stages. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.
© 2018 International Society for Neurochemistry.

Entities:  

Keywords:  CPT1c; PGC-1α; brain fatty acid metabolism; glycogen; ketone bodies; neurodegeneration

Mesh:

Year:  2018        PMID: 30295916     DOI: 10.1111/jnc.14605

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

2.  Bulbocodin D ameliorate cognitive impairment in APP/PS1 transgenic mice by modulating amyloid-beta burden, oxidative status and neuroinflammation.

Authors:  Fengjin Hao; Yueqin Feng
Journal:  Psychopharmacology (Berl)       Date:  2021-04-03       Impact factor: 4.530

3.  Altered Energy Metabolism During Early Optic Nerve Crush Injury: Implications of Warburg-Like Aerobic Glycolysis in Facilitating Retinal Ganglion Cell Survival.

Authors:  Jingyi Zhu; Ping Li; Yuan-Guo Zhou; Jian Ye
Journal:  Neurosci Bull       Date:  2020-04-10       Impact factor: 5.203

4.  Dichloroacetate Stabilizes Mitochondrial Fusion Dynamics in Models of Neurodegeneration.

Authors:  Darren O'Hara; Gavin M Davis; Natalie A Adlesic; Jerrard M Hayes; Gavin P Davey
Journal:  Front Mol Neurosci       Date:  2019-09-18       Impact factor: 5.639

5.  GLP-1 Receptor Signaling in Astrocytes Regulates Fatty Acid Oxidation, Mitochondrial Integrity, and Function.

Authors:  Katharina Timper; Almudena Del Río-Martín; Anna Lena Cremer; Stephan Bremser; Jens Alber; Patrick Giavalisco; Luis Varela; Christian Heilinger; Hendrik Nolte; Aleksandra Trifunovic; Tamas L Horvath; Peter Kloppenburg; Heiko Backes; Jens C Brüning
Journal:  Cell Metab       Date:  2020-05-19       Impact factor: 27.287

6.  Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration.

Authors:  Vignayanandam Ravindernath Muddapu; V Srinivasa Chakravarthy
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

Review 7.  Covering the Role of PGC-1α in the Nervous System.

Authors:  Zuzanna Kuczynska; Erkan Metin; Michal Liput; Leonora Buzanska
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

Review 8.  Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation.

Authors:  Changjing Wang; Tongtong Yang; Meiyu Liang; Junxia Xie; Ning Song
Journal:  Transl Neurodegener       Date:  2021-10-18       Impact factor: 8.014

9.  Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys.

Authors:  Marc Morissette; Mélanie Bourque; Marie-Ève Tremblay; Thérèse Di Paolo
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.